Recalls & Warnings October 06, 2004 False Claims Made by Marketer of Cortisol-related Weight-Loss Supplements According to FTC On October 6, 2004, the Federal Trade Commission (FTC)charged marketers of two dietary supplements with claiming, falsely and without substantiation, that their products can cause weight loss and reduce the risk of, or prevent, serious health conditions
BPC 157
Venture capital and corporate investments in regenerative medicine, tissue engineering, and peptide therapeutics have surged, reflecting a broader trend toward biologically active compounds
labs and includes Certificate of Analysis documentation with every batch
They are not looking for a quick fix
Yet, as patients seek more natural and sustainable options, peptide therapy is gaining attention for its metabolism-enhancing and fat-reducing effects